Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnson Mak

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cell Reports|February 2, 2022
Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entryBelinda L Spillings, Christopher J Day, Albert Garcia-Minambres, et al.
Retrovirology|August 23, 2019
A trip down memory lane with RetrovirologyMonsef Benkirane, Ben Berkhout, Persephone Borrow, et al.
Cell Reports|May 12, 2021
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8<sup>+</sup> T cell antiviral responsesHongbing Yang, Anuska Llano, Samandhy Cedeño, et al.
Blood|March 18, 2011
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN productionAndrew N Harman, Joey Lai, Stuart Turville, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeletonPaul U Cameron, Suha Saleh, Georgina Sallmann, et al.
The Journal of Biological Chemistry|December 1, 2017
Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵSebastian A Stifter, Antony Y Matthews, Niamh E Mangan, et al.
Cellular Microbiology|November 6, 2009
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cellsMaria Kaparakis, Lynne Turnbull, Leticia Carneiro, et al.
Retrovirology|July 28, 2016
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κBSuha Saleh, Hao K Lu, Vanessa Evans, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Journal of Virology|April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse"Peter Speck, Jason Mackenzie, Rowena A Bull, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cell Reports|February 2, 2022
Host glycocalyx captures HIV proximal to the cell surface via oligomannose-GlcNAc glycan-glycan interactions to support viral entryBelinda L Spillings, Christopher J Day, Albert Garcia-Minambres, et al.
Retrovirology|August 23, 2019
A trip down memory lane with RetrovirologyMonsef Benkirane, Ben Berkhout, Persephone Borrow, et al.
Cell Reports|May 12, 2021
Incoming HIV virion-derived Gag Spacer Peptide 2 (p1) is a target of effective CD8<sup>+</sup> T cell antiviral responsesHongbing Yang, Anuska Llano, Samandhy Cedeño, et al.
Blood|March 18, 2011
HIV infection of dendritic cells subverts the IFN induction pathway via IRF-1 and inhibits type 1 IFN productionAndrew N Harman, Joey Lai, Stuart Turville, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeletonPaul U Cameron, Suha Saleh, Georgina Sallmann, et al.
The Journal of Biological Chemistry|December 1, 2017
Defining the distinct, intrinsic properties of the novel type I interferon, IFNϵSebastian A Stifter, Antony Y Matthews, Niamh E Mangan, et al.
Cellular Microbiology|November 6, 2009
Bacterial membrane vesicles deliver peptidoglycan to NOD1 in epithelial cellsMaria Kaparakis, Lynne Turnbull, Leticia Carneiro, et al.
Retrovirology|July 28, 2016
HIV integration and the establishment of latency in CCL19-treated resting CD4(+) T cells require activation of NF-κBSuha Saleh, Hao K Lu, Vanessa Evans, et al.
Clinical & Translational Immunology|March 18, 2021
Antibodies to neutralising epitopes synergistically block the interaction of the receptor-binding domain of SARS-CoV-2 to ACE 2Manisha Pandey, Victoria Ozberk, Sharareh Eskandari, et al.
Journal of Virology|April 25, 2023
Statement in Support of: "Virology under the Microscope-a Call for Rational Discourse"Peter Speck, Jason Mackenzie, Rowena A Bull, et al.
Pageof 9